BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8641402)

  • 1. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis.
    Jacobsson S; Carneskog J; Ridell B; Wadenvik H; Swolin B; Kutti J
    Eur J Haematol; 1996 May; 56(5):287-92. PubMed ID: 8641402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of megakaryocyte ploidy in patients with thrombocytosis.
    Kanz L; Hollen C; Friese P; Burstein SA
    Int J Cell Cloning; 1990 Jul; 8(4):299-306. PubMed ID: 2401806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts.
    Tomer A; Friese P; Conklin R; Bales W; Archer L; Harker LA; Burstein SA
    Blood; 1989 Aug; 74(2):594-601. PubMed ID: 2752135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryocyte ploidy in thrombocytosis: improved microdensitometric measurements with a new image analysis system.
    Woods MJ; Greaves M; Trowbridge EA
    Eur J Haematol; 1990 Apr; 44(4):220-6. PubMed ID: 2344884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low megakaryocyte ploidy in Ph-positive chronic myelogenous leukemia measured by flow cytometry.
    Jacobsson S; Wadenvik H; Kutti J; Swolin B
    Am J Clin Pathol; 1999 Feb; 111(2):185-90. PubMed ID: 9930139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endomitotic index of megakaryocytes measured by flow cytometry helps to diagnose hematological disorders with abnormal platelet counts.
    Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
    Anticancer Res; 1998; 18(5A):3347-53. PubMed ID: 9858907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megakaryocytes and platelets in myeloproliferative disorders.
    Briere J; Kiladjian JJ; Peynaud-Debayle E
    Baillieres Clin Haematol; 1997 Feb; 10(1):65-88. PubMed ID: 9154316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3.
    Kobayashi S; Teramura M; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
    Br J Haematol; 1993 Apr; 83(4):539-44. PubMed ID: 7686030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombocytosis versus thrombocythemia--differential diagnosis of elevated platelet count].
    Thiele J; Kvasnicka HM
    Pathologe; 2000 Jan; 21(1):31-8. PubMed ID: 10663667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurements of in vivo megakaryocytopoiesis: studies in nonhuman primates and patients.
    Tomer A; Harker LA
    Stem Cells; 1996; 14 Suppl 1():18-30. PubMed ID: 11012199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin levels in patients with primary and reactive thrombocytosis.
    Cerutti A; Custodi P; Duranti M; Noris P; Balduini CL
    Br J Haematol; 1997 Nov; 99(2):281-4. PubMed ID: 9375739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF.
    Li Y; Hetet G; Maurer AM; Chait Y; Dhermy D; Briere J
    Br J Haematol; 1994 Jul; 87(3):471-6. PubMed ID: 7993786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.
    Ebid GT; Ghareeb M; Salaheldin O; Kamel MM
    Int J Clin Exp Pathol; 2015; 8(9):11555-9. PubMed ID: 26617890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis.
    Mitterbauer G; Winkler K; Gisslinger H; Geissler K; Lechner K; Mannhalter C
    Am J Clin Pathol; 1999 Jul; 112(1):93-100. PubMed ID: 10396290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis--features of significance for the diagnosis of primary (essential) thrombocythaemia.
    Thiele J; Schneider G; Hoeppner B; Wienhold S; Zankovich R; Fischer R
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):407-17. PubMed ID: 3140482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bone marrow megakaryocyte ploidy distributions in persons with normal and abnormal platelet counts.
    Mazur EM; Lindquist DL; de Alarcon PA; Cohen JL
    J Lab Clin Med; 1988 Feb; 111(2):194-202. PubMed ID: 3276801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
    Ryningen A; Apelseth T; Hausken T; Bruserud Ø
    Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
    Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.